Clinical trial
Exemestane in Reducing Breast Density in Postmenopausal Women at Risk for Breast…
NCT00066586 · NCIC Clinical Trials Group, Other · Completed
Key facts
| NCT number | NCT00066586 |
|---|---|
| Title | Exemestane in Reducing Breast Density in Postmenopausal Women at Risk for Breast Cancer |
| Official title | A Randomized Study Of The Effect Of Exemestane (Aromasin) Versus Placebo On Breast Density In Postmenopausal Women At Increased Risk For Development Of Breast Cancer |
| Lead sponsor | NCIC Clinical Trials Group, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | exemestane, Placebo |
| Enrollment | 98 |
| Start date | Aug 1, 2001 |
| Primary completion | Nov 16, 2007 |
| Completion | Feb 10, 2009 |
| First posted | Aug 7, 2003 |
| Last update posted | Apr 2, 2020 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: